Letter by Al-Atassi et al Regarding Article, "Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial"

Circulation. 2015 Jul 7;132(1):e10. doi: 10.1161/CIRCULATIONAHA.114.014001.

Authors

Talal Al-Atassi¹, Maria Lorena Rodriguez¹, Marc Ruel²

Affiliations

¹ Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, ON, Canada.
² Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, ON, Canada, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada.

PMID: 26149431
DOI: 10.1161/CIRCULATIONAHA.114.014001

No abstract available

Publication types

Letter
Comment

MeSH terms

Coronary Artery Bypass / economics*
Coronary Artery Bypass / methods*
Coronary Artery Disease*
Drug-Eluting Stents / economics*
Female
Humans
Male
Percutaneous Coronary Intervention / economics*
Percutaneous Coronary Intervention / methods*